Clinical Research Directory
Browse clinical research sites, groups, and studies.
Swedish Trial on Embolization of Middle Meningeal Artery Versus Surgical Evacuation in Chronic Subdural Hematoma
Sponsor: Region Skane
Summary
The SWEMMA trial is an open, national, multi-center, prospective, randomized (1:1), superiority trial designed to assess impact on reoperation rates for chronic subdural hematoma with a head-to-head comparison of embolization of the middle meningeal artery (intervention) with standard neurosurgical hematoma evacuation (control).
Key Details
Gender
All
Age Range
18 Years - 89 Years
Study Type
INTERVENTIONAL
Enrollment
288
Start Date
2022-03-28
Completion Date
2027-03
Last Updated
2024-04-09
Healthy Volunteers
No
Conditions
Interventions
Endovascular treatment of the middle meningeal artery
The middle meningeal artery on the same side(s) as the chronic subdural hematoma is embolized with liquid embolic agents.
Standard neurosurgical hematoma evacuation
Standard neurosurgical evacuation of chronic subdural hematoma through burr-hole or mini craniotomy and postoperative subdural or subgaleal drainage.
Locations (4)
Sahlgenska University Hospital
Gothenburg, Sweden
Skåne University Hospital
Lund, Sweden
Karolinska Hospital
Stockholm, Sweden
Norrlands Universitetssjukhus
Umeå, Sweden